Sign in

CIK 0001574232 · Non-accelerated filer

Addex Therapeutics Ltd.

Sign in to watch
Ticker
ADXN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Switzerland
Entity type
other
Phone
01141228841555
Business address
CHEMIN DES MINES 9, GENEVA, Switzerland, CH-1202
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 4 Derivatives Options or other derivatives
  8. 4 Grant or award HEAD OF TRANSLATIONAL SCIENCE acquired 306,765 shares (grant or award)
  9. 4 Grant or award Director acquired 219,561 shares (grant or award)
  10. 4 Grant or award CHIEF MEDICAL OFFICER acquired 392,837 shares (grant or award)
  11. 4 Grant or award Director acquired 219,561 shares (grant or award)
  12. 4 Grant or award Director acquired 2,507,487 shares (grant or award)
  13. 4 Grant or award Director acquired 1,365,532 shares (grant or award)
  14. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 16,413,787 shares (grant or award)
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. 6-K Event Report of Foreign Issuer
  18. 6-K Event Report of Foreign Issuer
  19. 6-K Event Report of Foreign Issuer
  20. 6-K Event Report of Foreign Issuer

Page 1 of 14 · 280 filings